2 results
Approved WMORecruiting
The proposed pilot study will examine whether radiation-based CTA could be replaced with MRI in three phases of AAA management.
Approved WMORecruiting
This Phase II, open-label, multicenter study, will evaluate the safety, efficacy, and pharmacokinetics of glofitamab in combination with R-CHOP in individuals with ctDNA high-risk DLBCL in the first-line setting. Specific objectives and…